Heron Therapeutics, Inc. · NASDAQ:HRTX

Collard Craig A exercised options for 84,810 Heron Therapeutics, Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed May 4, 2026

On Apr 30, 2026, Collard Craig A (Director, Chief Executive Officer) exercised options for 84,810 Heron Therapeutics, Inc. shares, leaving 757,885 shares. Filed May 4, 2026 (Form 4).

Options exercised
84,810 shares
Holding after
757,885 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockOption exercise34,789696,841Direct
Apr 30, 2026Common StockOption exercise50,021757,885Direct

Source

View original at SEC

Related